HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
TRIB
Trinity Biotech plc
There isn't enough reported data to score TRIB yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
TRIB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
TRIB's revenue, profitability, cash flow and balance sheet are all currently under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
TRIB PE Valuation
TRIB has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
TRIB Forward outlook
There aren't enough analyst estimates for TRIB to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
TRIB has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus TRIB down 174%.
TRIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$60.60 | +$21.54 |
| Q3 2025 | -$68.28 | -$0.42 |
| Q2 2025 | -$73.86 | +$6.60 |
| Q1 2025 | -$85.44 | -$2.88 |
| Q4 2024 | -$82.14 | +$14.16 |
| Q3 2024 | -$67.86 | +$46.44 |
| Q2 2024 | -$80.46 | +$42.54 |
| Q1 2024 | -$82.56 | +$113.04 |
TRIB is still losing money, but far less than before: $60.60 per share over the past year, against $195.60 at its worst in early 2023.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus down 30% for TRIB.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
TRIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $11.1M | -30% |
| Q3 2025 | $14.2M | -6% |
| Q2 2025 | $11M | -31% |
| Q1 2025 | $7.6M | -48% |
| Q4 2024 | $15.9M | +18% |
| Q3 2024 | $15.2M | +3.2% |
| Q2 2024 | $15.8M | +14% |
| Q1 2024 | $14.7M | -0.8% |
TRIB's revenue has slid since its 2020 peak: $11M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -27% | +46 points |
| Q3 2025 | -3.8% | +13 points |
| Q2 2025 | -28% | -2.2 points |
| Q1 2025 | -62% | -42 points |
| Q4 2024 | -73% | -47 points |
| Q3 2024 | -17% | +14 points |
| Q2 2024 | -26% | +81 points |
| Q1 2024 | -21% | +5.8 points |
TRIB's operating margin was −27% last quarter, up 46 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
TRIB has the stronger cash trend. Its trailing FCF is up 4.7% versus its history, compared with HIMS at down 84%.
TRIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.5M | -351% |
| Q3 2025 | -$77.1K | +$6.2M |
| Q2 2025 | -$1.7M | +$2.6M |
| Q1 2025 | -$3M | +$3.3M |
| Q4 2024 | $615K | +$2.5M |
| Q3 2024 | -$6.3M | -$1M |
| Q2 2024 | -$4.3M | +$715K |
| Q1 2024 | -$6.3M | -$2.9M |
TRIB has burned cash in most quarters: −$6M over the past year, against −$16M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over TRIB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
TRIB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -950 shares |
| 1 year | +31% | +148K shares |
| 3 years | +144% | +367K shares |
| 5 years | +249% | +443K shares |
| Available history | +266% | +451K shares |
TRIB has 620,900 diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $270,000 |
| Q1 2024 | — |
TRIB hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
TRIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 12.0x | High |
| Q4 2021 | 7.5x | High |
| Q3 2021 | 16.9x | High |
| Q2 2021 | 5.2x | High |
| Q1 2021 | 11.4x | High |
| Q4 2020 | 24.1x | High |
| Q3 2020 | 3.5x | Elevated |
| Q2 2020 | 6.5x | High |
TRIB's net debt is about 12 years of its operating earnings (EBITDA), up from 11 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
TRIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.6 | Neutral |
| Stochastic | 10.5 | Oversold |
TRIB's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
TRIB PE vs Healthcare Sector
TRIB has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
TRIB has stronger trend alignment. HIMS is above 0 of 5 weekly averages versus TRIB above 0 of 3.
TRIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.56 | 10% below |
| 20 week MA | $8.71 | 32% below |
| 50 week MA | $16.5 | 64% below |
TRIB is in a downtrend: it's below all three of its weekly moving averages, and 64% below its 50-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over TRIB on returns for 2026, with the stronger performance.
TRIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $43.8 | $30.0 | -32% |
| 2026 YTD | $30.0 | $5.88 | -80% |
TRIB has finished every year since 2025 lower, and it's down 80% so far in 2026.